Today: September 30, 2024
Today: September 30, 2024

Latest From Reuters

Health

Abbott follows rival Dexcom with OTC glucose monitor launch in US

Abbott has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday, making it the second such device on the market to help

Abbott follows rival Dexcom with OTC glucose monitor launch in US
Australia|Economy|Finance|Health

Aussie consumers put essentials first as cost pressures persist

Australian households prioritised spending on essential services such as healthcare in July, choosing to save extra cash from recent tax cuts as they grappled with stubborn inflation and

Aussie consumers put essentials first as cost pressures persist
Americas|Health

Cuba faces uphill battle as Oropouche virus spreads

Cuban health authorities launched small-scale fumigation efforts in Havana on Friday to fight the spread of the Oropouche virus, but a rainy Caribbean summer, fuel shortages and

Cuba faces uphill battle as Oropouche virus spreads
Business|Economy|Finance|Health

Drug distributors strike $300 million opioid settlement with US health plans

The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they helped fuel the deadly U.S. opioid

Drug distributors strike $300 million opioid settlement with US health plans
Health

FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot.

FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain
Business|Finance|Health

Catalent beats revenue estimates ahead of deal close with Novo Holdings

Contract drug manufacturer Catalent beat analysts' estimates for fourth-quarter revenue on Thursday, helped by its biologics segment that develops and manufactures cell and gene therapies.

Catalent beats revenue estimates ahead of deal close with Novo Holdings
Africa|Health

Africa's mpox response is less than 10% funded, says Africa CDC

Africa has secured less than 10% of the estimated $245 million it needs to fight a surging mpox outbreak on the continent, a senior official from the Africa Centres for Disease

Africa's mpox response is less than 10% funded, says Africa CDC
Health

Philippines says two new mpox cases are milder variant

The Philippines has confirmed two more mpox virus infections of the milder clade 2 variety, its health ministry said Monday, bringing the number of active cases to three.

Philippines says two new mpox cases are milder variant
Business|Europe|Health

Nestle to keep Health Science unit after CEO's exit, chairman tells paper

(Widens distribution.)

Nestle to keep Health Science unit after CEO's exit, chairman tells paper
Africa|Health

Uganda confirms two more cases of mpox

Uganda has confirmed two more mpox virus infections, bringing the number of cases in the east African country to four, according to the health ministry. 

Uganda confirms two more cases of mpox
Health

Germany examining whether any available mpox vaccines could be donated

The German government is examining whether any available national mpox vaccine doses could be donated, the health ministry said in a status report for August that was seen

Germany examining whether any available mpox vaccines could be donated
Health

Singapore says it has detected 13 cases of mpox Clade 2 infection in 2024

Singapore has detected 13 cases of mpox Clade 2 infections this year, the health ministry said in a bulletin on Thursday.

Singapore says it has detected 13 cases of mpox Clade 2 infection in 2024
Asia|Economy|Health

Myanmar households crippled as currency tumbles to record low

A rapid depreciation of Myanmar's currency is pushing up the prices of essentials, including food and medicine, crippling ordinary households in the Southeast Asian country wrecked by

Myanmar households crippled as currency tumbles to record low
Health

Philippines says recent mpox case is mild Clade 2 variant

The Philippines' health minister said on Wednesday a recently detected mpox case in the Southeast Asian nation is of the mild Clade 2 variant and not the newer variant that has

Philippines says recent mpox case is mild Clade 2 variant
Business|Finance|Health

J&J to buy medical device maker V-Wave for up to $1.7 billion

Johnson & Johnson said on Tuesday it would buy privately held V-Wave for up to $1.7 billion, the healthcare conglomerate's second deal this year aimed at boosting its presence in the market

J&J to buy medical device maker V-Wave for up to $1.7 billion
Business|Finance|Health

Medtronic nudges profit forecast on medical devices demand, new launches

Medtronic slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and growth from its

Medtronic nudges profit forecast on medical devices demand, new launches
Health

One case of clade 2 mpox detected in Pakistan, new strain not detected

One case of the mpox virus has been detected in Pakistan of the clade 2 variety, the country's ministry of health said on Monday, adding that no cases of the clade 1b strain of

One case of clade 2 mpox detected in Pakistan, new strain not detected
Europe|Health

Greece partially lifts ban for transporting animals after goat plague

Greece said on Friday that it would partially lift a ban on transporting sheep and goats that it imposed last month after goat plague was detected in the country.

Greece partially lifts ban for transporting animals after goat plague
Business|Health

US patients take Wegovy obesity drug for around six months, Novo Nordisk says

U.S. patients are on average staying on Novo Nordisk's Wegovy weight-loss medication for just six months, an executive said on Wednesday, attributing the short time to the low

US patients take Wegovy obesity drug for around six months, Novo Nordisk says
Business|Health

Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet Holdings beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures.

Zimmer Biomet beats profit estimates on strong demand for medical devices
Business|Finance|Health

DaVita lifts annual profit forecast on strong kidney dialysis services demand

Healthcare company DaVita raised its 2024 profit forecast on Tuesday expecting strong demand for its kidney dialysis services, sending shares of the company up 3% in aftermarket trade.

DaVita lifts annual profit forecast on strong kidney dialysis services demand
Business|Finance|Health

Listerine-maker Kenvue beats estimates on strong essential health product sales

Kenvue beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped primarily by better-than-expected sales in its essential health products unit that sells brands

Listerine-maker Kenvue beats estimates on strong essential health product sales
Business|Europe|Health

BioNTech counts on shift to cancer drugs after second quarter losses quadruple

Losses at German drugmaker BioNTech quadrupled in the second quarter from a year earlier, the company said on Monday, as it banks on a strategy shift towards new cancer treatments

BioNTech counts on shift to cancer drugs after second quarter losses quadruple
Health

US FDA says all doses of Lilly's weight-loss and diabetes drug are now available

All doses of Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S.

US FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Business|Finance|Health

Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments

Vertex Pharmaceuticals raised its annual revenue forecast on Thursday, betting on robust demand for its cystic fibrosis (CF) treatments.

Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments

Follow